266 related articles for article (PubMed ID: 22576620)
21. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
22. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
[TBL] [Abstract][Full Text] [Related]
23. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
[TBL] [Abstract][Full Text] [Related]
24. Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.
Poormoghim H; Moghadam AS; Moradi-Lakeh M; Jafarzadeh M; Asadifar B; Ghelman M; Andalib E
Rheumatol Int; 2013 Aug; 33(8):1943-50. PubMed ID: 23344826
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.
Kuwana M; Okano Y; Kaburaki J; Tojo T; Medsger TA
Arthritis Rheum; 1994 Jun; 37(6):902-6. PubMed ID: 8003063
[TBL] [Abstract][Full Text] [Related]
26. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
27. Racial differences in the frequencies of scleroderma-related autoantibodies.
Reveille JD; Durban E; Goldstein R; Moreda R; Arnett FC
Arthritis Rheum; 1992 Feb; 35(2):216-8. PubMed ID: 1734910
[TBL] [Abstract][Full Text] [Related]
28. Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.
Reese C; Perry B; Heywood J; Bonner M; Visconti RP; Lee R; Hatfield CM; Silver RM; Hoffman S; Tourkina E
Arthritis Rheumatol; 2014 Jul; 66(7):1909-19. PubMed ID: 24578173
[TBL] [Abstract][Full Text] [Related]
29. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.
Hamaguchi Y; Hasegawa M; Fujimoto M; Matsushita T; Komura K; Kaji K; Kondo M; Nishijima C; Hayakawa I; Ogawa F; Kuwana M; Takehara K; Sato S
Br J Dermatol; 2008 Mar; 158(3):487-95. PubMed ID: 18205876
[TBL] [Abstract][Full Text] [Related]
30. Anti-RNPC-3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate-to-Severe Gastrointestinal Dysmotility.
McMahan ZH; Domsic RT; Zhu L; Medsger TA; Casciola-Rosen L; Shah AA
Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1164-1170. PubMed ID: 30242973
[TBL] [Abstract][Full Text] [Related]
31. A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis.
Jandali B; Lyons M; Charles J; Zhang M; Theodore S; Pedroza C; Mayes MD; Assassi S
Arthritis Care Res (Hoboken); 2024 Jun; 76(6):768-776. PubMed ID: 38221717
[TBL] [Abstract][Full Text] [Related]
32. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
33. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
Arnett FC; Gourh P; Shete S; Ahn CW; Honey RE; Agarwal SK; Tan FK; McNearney T; Fischbach M; Fritzler MJ; Mayes MD; Reveille JD
Ann Rheum Dis; 2010 May; 69(5):822-7. PubMed ID: 19596691
[TBL] [Abstract][Full Text] [Related]
34. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
[TBL] [Abstract][Full Text] [Related]
35. Association of HLA class II genes with systemic sclerosis in Koreans.
Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
[TBL] [Abstract][Full Text] [Related]
36. Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans.
Blanco I; Mathai S; Shafiq M; Boyce D; M Kolb T; Chami H; K Hummers L; Housten T; Chaisson N; L Zaiman A; M Wigley F; J Tedford R; A Kass D; Damico R; E Girgis R; M Hassoun P
Medicine (Baltimore); 2014 Jul; 93(5):177-185. PubMed ID: 25181310
[TBL] [Abstract][Full Text] [Related]
37. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
[TBL] [Abstract][Full Text] [Related]
38. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis.
Kim D; Peck A; Santer D; Patole P; Schwartz SM; Molitor JA; Arnett FC; Elkon KB
Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347
[TBL] [Abstract][Full Text] [Related]
39. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
